Literature DB >> 32016002

Is there value of tumor stromal infiltrating lymphocytes for response assessment to chemoradiation in esophageal squamous cell carcinoma?

Xin Wang1, Wang Jing2, Steven H Lin3.   

Abstract

Entities:  

Year:  2019        PMID: 32016002      PMCID: PMC6976488          DOI: 10.21037/atm.2019.11.82

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  22 in total

1.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Authors:  R Salgado; C Denkert; S Demaria; N Sirtaine; F Klauschen; G Pruneri; S Wienert; G Van den Eynden; F L Baehner; F Penault-Llorca; E A Perez; E A Thompson; W F Symmans; A L Richardson; J Brock; C Criscitiello; H Bailey; M Ignatiadis; G Floris; J Sparano; Z Kos; T Nielsen; D L Rimm; K H Allison; J S Reis-Filho; S Loibl; C Sotiriou; G Viale; S Badve; S Adams; K Willard-Gallo; S Loi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

2.  Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.

Authors:  Shannon K Swisher; Yun Wu; Carlos A Castaneda; Genvieve R Lyons; Fei Yang; Coya Tapia; Xiuhong Wang; Sandro A A Casavilca; Roland Bassett; Miluska Castillo; Aysegul Sahin; Elizabeth A Mittendorf
Journal:  Ann Surg Oncol       Date:  2016-03-10       Impact factor: 5.344

3.  Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.

Authors:  U Zingg; M Montani; D M Frey; S Dirnhofer; A J Esterman; P Went; D Oertli
Journal:  Eur J Surg Oncol       Date:  2010-05-26       Impact factor: 4.424

4.  The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Authors:  Hiroshi Miyata; Koji Tanaka; Tomoki Makino; Makoto Yamasaki; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Eiichi Morii; Masaki Mori; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2018-05-10       Impact factor: 5.344

5.  Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis.

Authors:  Xiao Zheng; Xing Song; Yingjie Shao; Bin Xu; Wenwei Hu; Qi Zhou; Lujun Chen; Dachuan Zhang; Changping Wu; Jingting Jiang
Journal:  Cell Physiol Biochem       Date:  2018-01-31

6.  Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

Authors:  Bo Jan Noordman; Manon C W Spaander; Roelf Valkema; Bas P L Wijnhoven; Mark I van Berge Henegouwen; Joël Shapiro; Katharina Biermann; Ate van der Gaast; Richard van Hillegersberg; Maarten C C M Hulshof; Kausilia K Krishnadath; Sjoerd M Lagarde; Grard A P Nieuwenhuijzen; Liekele E Oostenbrug; Peter D Siersema; Erik J Schoon; Meindert N Sosef; Ewout W Steyerberg; J Jan B van Lanschot
Journal:  Lancet Oncol       Date:  2018-06-01       Impact factor: 41.316

7.  Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.

Authors:  S J Luen; R Salgado; M V Dieci; A Vingiani; G Curigliano; R E Gould; C Castaneda; T D'Alfonso; J Sanchez; E Cheng; E Andreopoulou; M Castillo; S Adams; S Demaria; W F Symmans; S Michiels; S Loi
Journal:  Ann Oncol       Date:  2019-02-01       Impact factor: 32.976

8.  Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.

Authors:  Hao Zhang; Shan Tan; Wengen Chen; Seth Kligerman; Grace Kim; Warren D D'Souza; Mohan Suntharalingam; Wei Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-01       Impact factor: 7.038

9.  Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer.

Authors:  Kai Liu; Kun Yang; Bin Wu; HaiNing Chen; XiaoLong Chen; XinZu Chen; LiLi Jiang; FuXiang Ye; Du He; ZhengHao Lu; Lian Xue; WeiHan Zhang; Qiu Li; ZongGuang Zhou; XianMing Mo; JianKun Hu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.

Authors:  Hong Yang; Hui Liu; Yuping Chen; Chengchu Zhu; Wentao Fang; Zhentao Yu; Weimin Mao; Jiaqing Xiang; Yongtao Han; Zhijian Chen; Haihua Yang; Jiaming Wang; Qingsong Pang; Xiao Zheng; Huanjun Yang; Tao Li; Florian Lordick; Xavier Benoit D'Journo; Robert J Cerfolio; Robert J Korst; Nuria M Novoa; Scott J Swanson; Alessandro Brunelli; Mahmoud Ismail; Hiran C Fernando; Xu Zhang; Qun Li; Geng Wang; Baofu Chen; Teng Mao; Min Kong; Xufeng Guo; Ting Lin; Mengzhong Liu; Jianhua Fu
Journal:  J Clin Oncol       Date:  2018-08-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.